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severe thymic defects. This study illus-
trates how, as a result of a block in thymic
development, additional functions of the
deleted molecule can be masked in the
periphery, and therefore, both peripheral
and thymic function may need to be eval-
uated separately before a proper under-
standing of the molecular basis for such
autoimmune syndromes can be appreci-
ated.
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Antigen cross-presentation enables an efficient CD8+ T cell response against antigens from exogenous
sources. In this issue of Immunity, Bougne`res et al. (2009) identify lipid bodies as an unexpected new player
involved in this complex cellular pathway.Lipid bodies (LBs), also referred to as
lipid droplets, are dynamic organelles
made of a core in which neutral lipids
accumulate, surrounded by a hemimem-
brane (monolayer) composed of phopho-
lipids, cholesterol, and a variety of
proteins. LBs are present in virtually all
cell types. Evidence indicated that LBs
originate from the endoplasmic reticulum
(ER) or a subregion of this organelle
(Murphy et al., 2009). Although this organ-
elle was originally considered to be
a simple lipid inclusion, with a role in lipid
storage and metabolism, recent studies
have clearly demonstrated that LBs
interact with several organelles and struc-
tures within cells, including phagosomes
(van Manen et al., 2005), autophago-
somes, and the proteasome (Fujimoto
et al., 2008), suggesting a role for LBs in
cellular processes related to antigen
processing and immunity. The study by
Bougne`res et al. (2009), in this issue of176 Immunity 31, August 21, 2009 ª2009 ElsImmunity, unexpectedly reveals the in-
volvement of LBs in adaptive immunity.
Cross-presentation plays a key role in
the elaboration of a sustained and effi-
cient immune response by enabling the
presentation of exogenous antigens on
MHC class I molecules and CD8+ T cells
stimulation against a variety of pathogens
causing diseases such as tuberculosis,
salmonellosis, and leishmaniasis, as well
as tumor cells. However, exogenous anti-
gens are not uniquely coming from foreign
molecules. ‘‘Exogenous antigens’’ is used
as a term to illustrate that the antigenic
peptides do not come from the antigen-
presenting cell (APC) itself, but rather
from surrounding apoptotic bodies or
cell fragments (self-proteins) internalized
by endocytosis, macropinocytosis, or
phagocytosis, or from microorganisms
(nonself-proteins) engulfed at sites of
infection. These cells or cell fragments are
sequestered in a membrane organelleevier Inc.called phagosome in order to promote
the establishment of conditions that will
enable the killing of microorganisms, and
the hydrolytic degradation of the phago-
some content, within a compartment iso-
lated from the rest of the cell. These
conditions are attained by a complex
maturation process allowing the trans-
formation of newly formed phagosomes
into phagolysosomes. Through interac-
tions with subsets of endocytic organelles
and Golgi-derived vesicles, the phago-
some fills with hydrolases and acquires
the molecular machines necessary for the
acidification of its lumen and the genera-
tion of superoxides contributing to its lytic
and microbicidal properties. According to
the classical view on antigen presenta-
tion, peptides from exogenous sources,
generated in endocytic and phagocytic
organelles, are mainly presented on MHC
class II molecules to trigger a CD4+ T cell
response. This contrasts with a second
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PreviewsFigure 1. Involvement of Lipid Bodies in Cross-presentation
Irgm3 present on the ER membrane also associates to lipid bodies, budding from the outer ER membrane.
The transient interaction between LBs and phagosomes, also observed in the Bougne`res et al. study,
might favor a reorganization of the outer membrane of phagosomes and the association of cytoplasmic
anchored proteins. This would improve the link needed between the processing of peptides in phago-
somes and their loading on MHC class I molecules. Note that the molecular mechanisms enabling the
translocation of peptides from the phagosome lumen to the cytoplasm is still poorly defined.antigen-presentation pathway that en-
ables the processing of endogenous anti-
gens into smaller peptides by the protea-
some in the cytoplasm and their loading
on MHC class I molecules in the ER for
presentation at the cell surface to CD8+
T lymphocytes. The finding that several
microorganisms present within phago-
somes induced a strong CD8+ T cell re-
sponse was pivotal to the proposal that
cellular mechanisms existed to enable
the loading of exogenous peptides on
MHC class I molecules. The most ac-
cepted model of antigen cross-presenta-
tion, proposed by Ken Rock, argued that
peptides generated in the lumen of phag-
osomes are translocated into the cyto-
plasm, where they intersect the classical
MHC class I pathway (for a review, see
Vyas et al., 2008).
The understanding of the molecular
mechanisms enabling cross-presentation
has been shaped by our knowledge of
the complex membrane trafficking events
and interactions occurring between vari-
ous organelles within APCs. My group,
along with the groups of Sebastian Ami-
gorena and Peter Creswell, proposed
that cross-presentation was favored by
close interactions between phagosomes
and the molecular machines involved in
the MHC class I pathway, including ER
and the proteasome (discussed in Vyas
et al., 2008). The study of Bougne`reset al. (2009) introduces a player, the lipid
body, into the complex cross-presenta-
tion pathway. Bougne`res et al. (2009)
demonstrate that a GTPase of the p47
family, Irgm3, play a key role in cross-
presentation by showing that dendritic
cells (DCs) isolated from Irgm3-deficient
mice display impaired abilities in stimu-
lating ovalbumin (OVA)-specific CD8+
T cells after phagocytosis of OVA-coated
latex beads. In contrast, the processing
and presentation of OVA on MHC class
II molecules, for CD4+ T cell activation,
was unaffected. This set of experiments
clearly established that only cross-pre-
sentation is linked to Irgm3 activity. They
then used immunofluorescence to show
that Irgm3 localizes to part of the ER and
to vesicular structures that they were
able to identify as LBs, providing the first
hint of the involvement of this organelle
in Irgm3-mediated cross-presentation
(Figure 1). In that context, they were able
to show that DCs isolated from Irgm3-
deficient animals displayed markedly less
LBs than DCs from wild-type animals. It is
well established that the expression of
proteins of the p47 family, including
Irgm3, is strongly upregulated by inter-
feron-g (IFN-g), a result confirmed in the
Bougneres et al. study. Furthermore, this
study indicated that treatment with IFN-g
strongly stimulated LBs formation in wild-
type DCs, but had no such effect in DCsImmunity 3isolated from Irgm3-deficient animals.
Altogether, these results indicated that
Irgm3 is involved in both cross-presenta-
tion and the biogenesis of LBs. However,
it remained to be demonstrated whether
LBs directly influenced cross-presenta-
tion. The involvement of LBs in cross-pre-
sentation was first supported by results
showing that DCs displaying high amount
of LBs are more efficient at cross-presen-
tation than cells displaying lower amounts
of LBs, in conditions in which the amount
of antigen internalized was equal in all
DCs. Further support for a role of LBs in
cross-presentation came from experi-
ments in which LB biogenesis was al-
tered by treatment with xanthohumol, an
inhibitor of diacylglycerol acyltransferase
(a protein involved in triglyceride storage),
that substantially decrease the number
of LBs in DCs. Treatment with this drug
also strongly inhibited cross-presentation,
thereby highlighting the link between the
presence of LBs in DCs and the ability of
these cells to cross-present exogenous
antigens. It cannot be ruled out, how-
ever, that this drug influences the overall
amount or distribution of Irgm3 in the cell
and thus affects cross-presentation and
LB biogenesis independently.
A key question is, what are the molec-
ular mechanisms linking Irgm3, LBs, and
phagosomes and their respective involve-
ment in cross-presentation? Interesting
hints are provided by the study of Boug-
ne`res et al. (2009). The fact that the
loading of exogenous peptides on MHC
class II molecules, occurring in the phag-
osome lumen, was not affected in Irgm3-
deficient DCs suggest that Irgm3 might
play a role in the step required to transfer
exogenous antigens from the phagosome
lumen to the MHC I pathway. This is sup-
ported by results showing that DCs from
Irgm3-deficient mice are able to stimulate
CD8+ T cells efficiently when peptides are
delivered directly in the cytoplasm (this is
made possible by infecting cells with
Listeria monocytogenes expressing OVA,
a bacteria that reach the cytoplasm after
rapid lysis of the phagosome membrane).
This is also supported by results showing
that DCs isolated from Irgm3-deficient
mice can stimulate CD8+ T cells when
a high concentration of OVA is loaded.
Interestingly, OVA internalized by phago-
cytosis at high concentrations in DCs
isolated from TAP (transporter associ-
ated with antigen processing)-deficient1, August 21, 2009 ª2009 Elsevier Inc. 177
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Previewsanimals could still be cross-presented to
CD8+ T cells (Bertholet et al., 2006). Be-
cause TAP is required for the transloca-
tion of peptides from the cytoplasm to
the ER lumen, these results suggest that
direct loading of exogenous peptides on
MHC class I molecules occurred directly
in the phagosome lumen. The efficiency
of this process appeared, however, to
be limited. Hence, Irgm3 would enhance
cross-presentation by improving the mo-
lecular mechanisms connecting the early
step of protein processing in phagosomes
with the loading of peptides on MHC class
I molecules. A surprising result revealed
by Bougne`res et al. (2009) is that although
Irgm3+ LBs were often observed in the
close vicinity of phagosomes, no notice-
able accumulation of Irgm3 was observed
on these organelles by immunofluores-
cence. This observation suggests that
Irgm3 has an indirect effect on the
phagosomal cross-presentation machin-
ery, possibly through LBs. We have
shown recently, by using quantitative pro-
teomics analyses, that the relative amount
of several members of the p47 family,
including Irgm3, increased markedly on
phagosomes isolated from macrophages
treated with IFN-g, compared to control
cells (Trost et al., 2009). These resultsBlimp Hovers over
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The functions of T lymphocytes are
studies in this issue of Immunity (K
that the transcriptional repressor Bli
lates clonal exhaustion.
The B cell transcriptional repressor
Blimp-1 (B lymphocyte-induced matura-
tion protein-1), encoded by the Prdm1
gene locus, is known as a decision maker
in the fate of B cells by regulating genes
promoting B cell terminal differentiation
into plasma cells but not into memory B
cells (Shaffer et al., 2002; Shapiro-Shelef
178 Immunity 31, August 21, 2009 ª2009 Elswould rather argue that Irgm3 is directly
involved in the ability of phagosomes to
participate in cross-presentation. Another
effect of IFN-g highlighted in recent
studies is the ability of this cytokine to
modulate the conditions encountered in
the phagosome lumen to promote a
limited hydrolysis of proteins favoring the
generation of peptides suited for loading
on MHC molecules (Yates et al., 2007;
Trost et al., 2009). Interestingly, Boug-
ne`res et al. (2009) indicate that Irgm3
inhibits phagosome maturation, without
altering the rate of phagocytosis, a pro-
cess that should, in principle, limit the
rapid proteolysis of peptides and favor
antigen presentation.
More studies will highlight the relative
contribution of Irgm3 and LBs to cross-
presentation, as well as the role of this
protein in the interaction between phago-
somes and LBs. A thorough characteriza-
tion of the molecular organization and
biogenesis of LBs will also provide key
elements to understanding the molecular
nature of the interaction occurring be-
tween LBs and the other organelles in-
volved in cross-presentation, including
phagosomes and autophagosomes. Con-
sidering the fact that LBs display a mono-
layer membrane, one might argue that thisT Cell Immunity
chusetts Medical School, Worcester, MA 0165
.edu
regulated by transcription factors c
allies et al., 2009; Rutishauser et a
mp-1 promotes the development of
et al., 2003). More recent studies, including
three in this issue of Immunity, indicate
that Blimp-1 may provide similar functions
for CD8+ T cells, by promoting the terminal
differentiation of most into short-lived
cytotoxic T lymphocytes (CTLs) rather
than long-lived central memory (CM)
T cells (Kallies et al., 2009; Rutishauser
evier Inc.type of interaction might influence the
lipid organization of the outer membrane
of these organelles and/or the associ-
ation of cytoplasmic anchored proteins
like Irgm3.
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